Home > SOP Information > SOPs and Supporting Information – alphabetic listing > E to G > Gastric Ulcer and Duodenal Ulcer J004 > Rulebase for gastric ulcer and duodenal ulcer > Non-topical non-steroidal anti-inflammatory drug

Non-topical non-steroidal anti-inflammatory drug

Gastric ulcer and duodenal ulcer - Non-topical non-steroidal anti-inflammatory drug Factor

Last reviewed for CCPS 24 May 2007.

Investigative Documents

Claimant Report - Non-Topical Non-Steroidal Anti-Inflammatory Drugs - Gastric Ulcer and Duodenal Ulcer [CR9146]

[1] Medical Report - Treatment with Non-Topical NSAIDs -  Gastric Ulcer and Duodenal Ulcer [MR9196]

Preliminary questions [1462]

[2]30136

there is some evidence that non-topical non-steroidal anti-inflammatory drugs may be a factor in the development or worsening of the condition under consideration.

1475 [3] the veteran was treated with a non-topical non-steroidal anti-inflammatory drug at least every other day during a continuous period of at least two weeks within the two months before the clinical onset or worsening of the condition under consideration.

[4]27317

the veteran's treatment with a non-topical non-steroidal anti-inflammatory drug at least every other day during a continuous period of at least two weeks was materially contributed to by treatment of an injury or illness which is identifiable.

1478 — the veteran has established the causal connection between the treatment with non-topical non-steroidal anti-inflammatory drugs and VEA service for gastric ulcer or duodenal ulcer.

1479 — the veteran has established the causal connection between the treatment with non-topical non-steroidal anti-inflammatory drugs and VEA service for the clinical onset of gastric ulcer or duodenal ulcer.

6185 — the veteran has established the causal connection between the treatment with non-topical non-steroidal anti-inflammatory drugs and eligible service for the clinical onset of gastric ulcer or duodenal ulcer.

or

6184 — the veteran has established the causal connection between the treatment with non-topical non-steroidal anti-inflammatory drugs and operational service for the clinical onset of gastric ulcer or duodenal ulcer.

or

[5]7334

the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service.

[6]7335

the condition under consideration permanently worsened.

4218 — the veteran has established the causal connection between the treatment with non-topical non-steroidal anti-inflammatory drugs and VEA service for the clinical worsening of gastric ulcer or duodenal ulcer.

6187 — the veteran has established the causal connection between the treatment with non-topical non-steroidal anti-inflammatory drugs and eligible service for the clinical worsening of gastric ulcer or duodenal ulcer.

or

6186 — the veteran has established the causal connection between the treatment with non-topical non-steroidal anti-inflammatory drugs and operational service for the clinical worsening of gastric ulcer or duodenal ulcer.

Clinical onset and operational service [6184]

[7]27316

the identified illness or injury made a material contribution to the veteran's treatment with a non-topical non-steroidal anti-inflammatory drug at least every other day during a continuous period of at least two weeks within the two months before the clinical onset of the condition under consideration.

1480 — the identified illness or injury, which materially contributed to the veteran's treatment with non-topical non-steroidal anti-inflammatory drugs, is causally related to operational service. [8] [9]

Clinical onset and eligible service [6185]

[10]37636

the identified illness or injury made a material contribution to the veteran's treatment with a non-topical non-steroidal anti-inflammatory drug at least every other day during a continuous period of at least four weeks.

[11]5398

the identified illness or injury made a material contribution to the veteran's treatment with a non-topical non-steroidal anti-inflammatory drug at least every other day during a continuous period of at least four weeks within the two months before the clinical onset of the condition under consideration.

4219 — the identified illness or injury, which materially contributed to the veteran's treatment with non-topical non-steroidal anti-inflammatory drugs, is causally related to eligible service. [12] [9]

Clinical worsening and operational service [6186]

[13]5427

the identified illness or injury made a material contribution to the veteran's treatment with a non-topical non-steroidal anti-inflammatory drug at least every other day during a continuous period of at least two weeks within the two months before the clinical worsening of the condition under consideration.

1480 — the identified illness or injury, which materially contributed to the veteran's treatment with non-topical non-steroidal anti-inflammatory drugs, is causally related to operational service. [14] [9]

[15]6203

the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury, which materially contributed to the veteran's treatment with non-topical non-steroidal anti-inflammatory drugs, is causally related.

Clinical worsening and eligible service [6187]

[16]37636

the identified illness or injury made a material contribution to the veteran's treatment with a non-topical non-steroidal anti-inflammatory drug at least every other day during a continuous period of at least four weeks.

[11]5428

the identified illness or injury made a material contribution to the veteran's treatment with a non-topical non-steroidal anti-inflammatory drug at least every other day during a continuous period of at least four weeks within the two months before the clinical worsening of the condition under consideration.

4219 — the identified illness or injury, which materially contributed to the veteran's treatment with non-topical non-steroidal anti-inflammatory drugs, is causally related to eligible service. [17] [9]

[18]6204

the clinical onset of the condition under consideration occurred prior to that part of eligible service to which the identified illness or injury, which materially contributed to the veteran's treatment with non-topical non-steroidal anti-inflammatory drugs, is causally related. [19]

Source URL (modified on 20/10/2014 - 3:25pm): https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/e-g/gastric-ulcer-and-duodenal-ulcer-j004-k25k26k27/rulebase-gastric-ulcer-and-duodenal-ulcer/non-topical-non-steroidal-anti-inflammatory-drug

Links
[1] https://clik.dva.gov.au/ccpsclaimant-84
[2] https://clik.dva.gov.au/ccpsj004rc-3
[3] clikpopup://CCPS/Non-topical NSAIDs every other day for 2 weeks at some time
[4] clikpopup://CCPS/reject1475No
[5] clikpopup://CCPS/reject27317No
[6] clikpopup://CCPS/Reject/OnsetAfterService
[7] clikpopup://CCPS/Reject/NoPermanentWorsening
[8] clikpopup://CCPS/reject27316No
[9] clikpopup://CCPS/reject1480,4219No
[10] clikpopup://CCPS/Identified illness contributed to non-topical NSAIDs every other day for 4 weeks
[11] clikpopup://CCPS/reject37636No
[12] clikpopup://CCPS/reject5398No
[13] clikpopup://CCPS/Identified illness contributed to non-topical NSAIDs every other day for 2 weeks in 2 months before worsening of GUDU
[14] clikpopup://CCPS/reject5427No
[15] clikpopup://CCPS/Onset of GUDU prior to Op service to which identified illness treated with non-topical NSAIDs is related
[16] clikpopup://CCPS/reject6203No
[17] clikpopup://CCPS/reject5428No
[18] clikpopup://CCPS/Onset of GUDU prior to El service to which identified illness treated with non-topical NSAIDs is related
[19] clikpopup://CCPS/reject6204No